CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Ticker
- ACHV
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $175,177
- in 1 filing
Net −$175,177. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-08-01 | Cormack Scott Daniel Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2017-08-01 | Bencich John CFO | Grant or award · Stock Option (right to buy) | +274,000 | 274,000 | ||
| 2017-08-01 | Clarke Anthony President & CSO | Grant or award | +550,455 | 550,455 | ||
| 2017-08-01 | Clarke Anthony President & CSO | Grant or award | +359,305 | 359,305 | ||
| 2017-08-01 | Clarke Anthony President & CSO | Grant or award | +538,958 | 538,958 | ||
| 2017-08-01 | Clarke Anthony President & CSO | Grant or award | +176,418 | 176,418 | ||
| 2017-08-01 | Stewart Richard Alistair Chairman & CEO | Grant or award | +1,950,309 | 1,950,309 | ||
| 2017-08-01 | Stewart Richard Alistair Chairman & CEO | Grant or award | +71,861 | 71,861 | ||
| 2017-08-01 | Stewart Richard Alistair Chairman & CEO | Grant or award | +176,418 | 176,418 | ||
| 2017-08-01 | Bencich John CFO | Grant or award · Restricted Stock Unit (RSU) | +54,800 | 54,800 | ||
| 2017-08-01 | Bencich John CFO | Grant or award · Stock Option (right to buy) | +274,000 | 274,000 | ||
| 2017-08-01 | JACOBS CINDY EVP, CMO | Grant or award · Restricted Stock Unit (RSU) | +54,800 | 54,800 | ||
| 2017-08-01 | JACOBS CINDY EVP, CMO | Grant or award · Stock Option (right to buy) | +274,000 | 274,000 | ||
| 2017-08-01 | Cormack Scott Daniel Director | Option exercise | +3,125 | 16,302 | ||
| 2017-08-01 | Cormack Scott Daniel Director | Option exercise | +1,590 | 9,685 | ||
| 2017-08-01 | Cormack Scott Daniel Director | Option exercise · Restricted Stock Unit (RSU) | −568 | 0 | ||
| 2017-08-01 | Cormack Scott Daniel Director | Option exercise · Restricted Stock Unit (RSU) | −1,705 | 0 | ||
| 2017-08-01 | Cormack Scott Daniel Director | Option exercise · Restricted Stock Unit (RSU) | −852 | 0 | ||
| 2017-08-01 | Cormack Scott Daniel Director | Option exercise · Restricted Stock Unit (RSU) | −284 | 0 | ||
| 2017-08-01 | Cormack Scott Daniel Director | Option exercise · Restricted Stock Unit (RSU) | −852 | 0 |
Page 19 of 36 · 715 trades